INFORMAZIONI SU QUESTO ARTICOLO

Cita

1. Elghetany TM, Bhatla T. Myelodysplastic Syndromes and Myeloproliferative Disorders. Lanzkowsky P. Hofmann I. Jeffrey M. Lipton Lanzkowsky’s Manual of Pediatric Hematology and Oncology. Sixth Edition Elsevier. 2016, London, 348-351.Search in Google Scholar

2. Hasle H, Niemeyer CM, Chessells JM. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia. 2003;17(2):277-282. DOI: 10.1038/sj.leu.240276510.1038/sj.leu.240276512592323Open DOISearch in Google Scholar

3. Disperati P, Ichim CV, Tkachuk D. Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology. Leuk Res. 2006;30:233-239. DOI: 10.1016/j.leukres.2005.06.01110.1016/j.leukres.2005.06.01116046234Open DOISearch in Google Scholar

4. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;1145(5):937-51. DOI: 10.1182/blood-2009-03-20926210.1182/blood-2009-03-20926219357394Open DOISearch in Google Scholar

5. Tefferi A. Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol. 2005;23(33):8520-30. DOI: 10.1200/JCO.2004.00.9316 10.1200/JCO.2004.00.931616293880Open DOISearch in Google Scholar

6. Das P, Deepali J, Das R, Garewal G. Hyperfibrotic myelodysplastic syndrome: a report of three cases from north India. Turk J Hematol. 2009;26:93-6.Search in Google Scholar

7. Bowen D, Culligan D, Jowitt S, Kelsey S, Mufti G, Oscier D, et al. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. Br J Haematol. 2003;120(2):187-200. DOI: 10.1046/j.1365-2141.2003.03907.x10.1046/j.1365-2141.2003.03907.x12542475Open DOISearch in Google Scholar

8. Porwit A, Saft L. The AML-MDS interface-leukemic transformation in myelodysplastic syndromes. J Hematopathol. 2011;4:69-79. DOI: 10.1007/s12308-011-0088-610.1007/s12308-011-0088-6Search in Google Scholar

9. Diem H. Myelodysplasia. Tehml H, Diem H, Haferlach T. Color Atlas of Hematology - Practical Microscopic and Clinical Diagnosis. 2nd revised edition 2004. Munich, 106-9.Search in Google Scholar

10. Glaubach T, Robinson L.J, Corey S.J Pediatric Myelodysplastic Syndromes: They Do Exist! J Pediatr Hematol Oncol. 2014;36:1-7. DOI: 10.1097/MPH.000000000000004610.1097/MPH.000000000000004624345881Search in Google Scholar

11. Elghetany TM. Myelodysplastic syndromes in children: a critical review of issues in the diagnosis and classification of 887 cases from 13 published series. Arch Pathol Lab Med. 2007;131:1110-6.10.5858/2007-131-1110-MSICAC17617000Search in Google Scholar

12. Cîrstea M, Coliță A, Ionescu B, Ghiaur A, Vasilescu D, et al. Therapy-related myelodysplastic syndrome after successful treatment of acute promyelocytic leukemia: case report and literature review. Rev Romana Med Lab. 2017;25(2):165-79. DOI: 10.1515/rrlm-2017-001310.1515/rrlm-2017-0013Open DOISearch in Google Scholar

13. Camitta BM. Diseases of blood: Splenomegaly. Kliegman RM. Behrman RE, Jenson HB, Waldo E, Nelson Textbook of Pediatrics. 18th edition, Philadelphia, Elsevier, 2008, 2091-2.Search in Google Scholar

14. Leguit RJ, Van Den Tweel J.G. The pathology of bone marrow failure. Histopathology. 2010;57(5):655-670. DOI: 10.1111/j.1365-2559.2010.03612.x10.1111/j.1365-2559.2010.03612.x20727024Open DOISearch in Google Scholar

15. Bănescu C, Benedek I, Duicu C, Demian S, Voidăzan S. Cytogenetic findings and their prognostic impact in myelodysplastic syndrome patients. Rev Romana MedLab. 2011;19(2):139-47.Search in Google Scholar

16. Della Porta MG, Malcovati L. Myelodysplastic syndromes with bone marrow fibrosis, Haematol Hematol J. 2011;96:180-3. DOI: 10.3324/haematol.2010.03987510.3324/haematol.2010.039875303168221282718Open DOISearch in Google Scholar

17. Geddes AD, Bowen DT, Jacobs A. Clonal karyotype abnormalities and clinical progress in the myelodysplastic syndrome, Br J Haematol. 1990;76(2):194-202. DOI: 10.1111/j.1365-2141.1990.tb07871.x10.1111/j.1365-2141.1990.tb07871.x2094322Open DOISearch in Google Scholar

18. Bernasconi P, Klersy C, Boni M. Does cytogenetic evolution have may any prognostic relevance in myelodysplastic syndromes? Ann Hematol. 2010;89:545-551. DOI: 10.1007/s00277-010-0927-z10.1007/s00277-010-0927-z20217086Open DOISearch in Google Scholar

19. Koppel A, Schiller G. Myelodysplastic syndrome: an update on diagnosis and therapy. Curr Oncol Rep. 2008 10(5):372-378. DOI: 10.1007/s11912-008-0058-z10.1007/s11912-008-0058-z18706264Open DOISearch in Google Scholar

20. Xiaojun KS, Xu Min L. Hypocellular myelodysplastic syndrome with myelofibrosis in acute myeloid leukemia transformation: A case report. Oncol Lett. 2015;10:422-4.10.3892/ol.2015.3247448714026171043Search in Google Scholar

eISSN:
2284-5623
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Life Sciences, Molecular Biology, Biochemistry, Human Biology, Microbiology and Virology